DDX41 and acute myeloid leukemia: AML with DDX41 germline mutation has unique clinical characteristics such as male predominance, onset in the eighth decade of life, low white blood cell count, and favorable response to chemotherapy, and it is known to have an overall good prognosis [11, 12].